Hyperuricemia and adverse outcomes in cardiovascular disease: Potential for therapeutic intervention

被引:16
作者
Andrew R. Gavin
Allan D. Struthers
机构
[1] Department of Clinical Pharmacology, Ninewells Hospital
关键词
Uric Acid; Xanthine Oxidase; Allopurinol; Uric Acid Level; Serum Uric Acid Level;
D O I
10.2165/00129784-200303050-00001
中图分类号
学科分类号
摘要
High uric acid levels are associated with increased morbidity and mortality rates in cardiovascular disease. In this article we explore the relationship between cardiovascular disease and xanthine oxidase activity. We look at the evidence that uric acid and its production via the xanthine oxidase pathway, may directly contribute to this increased cardiovascular risk. We examine the relationship between uric acid and other established cardiovascular risk factors and look at the evidence that reducing uric acid production may have a beneficial impact on cardiovascular morbidity and mortality. We conclude that although there is currently insufficient evidence to recommend the routine use of xanthine oxidase inhibitors in those with cardiovascular disease and asymptomatic hyperuricemia, there is sufficient evidence to warrant a large scale morbidity and mortality trial.
引用
收藏
页码:309 / 314
页数:5
相关论文
共 79 条
[1]  
Liese A.D., Hense H.W., Lowel H., Et al., Association of serum uric acid with all cause and cardiovascular mortality and incident myocardial infarction in the MONICA Augsburg cohort, Epidemiology, 10, pp. 391-397, (1999)
[2]  
Leyva F., Anker S.D., Swan J., Et al., Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure, Eur. Heart J., 18, pp. 858-865, (1997)
[3]  
Wong K.Y.K., MacWalter R.S., Fraser H.W., Et al., Urate predicts subsequent cardiac death in stroke survivors, Eur. Heart J., 23, 10, pp. 788-793, (2002)
[4]  
Verdecchia P., Schillaci G., Reboldi G., Et al., Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study, Hypertension, 36, 6, pp. 1072-1078, (2000)
[5]  
Lehto S., Niskanen L., Ronnemaa T., Et al., Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus, Stroke, 29, pp. 635-639, (1998)
[6]  
Culleton B.F., Larson M.G., Kannel W.B., Et al., Serum uric acid and risk of cardiovascular disease and death: The Framingham Heart Study, Ann. Intern. Med., 131, pp. 7-13, (1999)
[7]  
Wannamethee S.G., Shaper A.G., Whincup P.H., Serum mate and the risk of major coronary heart disease events, Heart, 78, pp. 147-153, (1997)
[8]  
Facchini F., Chen Y.D.I., Hollenbeck C.B., Et al., Relationship between resistance to insullin-mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration, JAMA, 266, pp. 3008-3011, (1991)
[9]  
Bengtsson C., Lapidus S., Stendahl C., Et al., Hyperuricaemia and risk of cardiovascular disease and overall death: A 12-year follow-up of participants in the population study of Gothenburg, Sweden, Acta Med. Scand., 224, pp. 549-555, (1988)
[10]  
Kannel W.B., Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study, Am. J. Epidemiol., 121, pp. 11-18, (1985)